Author response for "Efficacy and safety of lobeglitazone versus sitagliptin as an add‐on to metformin in type 2 diabetes with metabolic syndrome over 24 weeks"

Diabetes, Obesity and Metabolism(2020)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要